SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000920465-17-000016
Filing Date
2017-01-06
Accepted
2017-01-06 18:23:13
Documents
1
Period of Report
2017-01-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_148374497590317.html 4  
1 FORM 4 wf-form4_148374497590317.xml 4 3945
  Complete submission text file 0000920465-17-000016.txt   5367
Mailing Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121
Business Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Issuer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O LA JOLLA PHARMACEUTICAL COMPANY LA JOLLA VILLAGE DRIVE, SUITE 1070 SAN DIEGO CA 92122
Business Address
Douglass Laura L. (Reporting) CIK: 0001589362 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36282 | Film No.: 17515425